An association between oral lichen planus and a persistently dry mouth

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 98, Issue 1, 2004, Pages 60-68

  Colquhoun, Angus N ^a   Ferguson, Martin M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; E-MAIL; HUMAN; LICHEN PLANUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; QUESTIONNAIRE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TELEPHONE; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LICHEN PLANUS, ORAL; LOGISTIC MODELS; MALE; MIDDLE AGED; QUESTIONNAIRES; XEROSTOMIA;

EID: 3242722049     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2003.11.003     Document Type: Article

References (57)

1. Bouquot J.E. Common oral lesions found during a mass screening examination. J Am Dent Assoc. 112:1986;50-57
2. Axell T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odontol Revy. 27:1976;1-103
3. Salonen L., Axell T., Hellden L. Occurrence of oral mucosal lesions, the influence of tobacco habits and an estimate of treatment time in an adult Swedish population. J Oral Pathol Med. 19:1990;170-176
4. Axell T., Zain R.B., Siwamogstham P., Tantiniran D., Thampipit J. Prevalence of oral soft tissue lesions in out-patients at two Malaysian and Thai dental schools. Community Dent Oral Epidemiol. 18:1990;95-99
5. Zain R.B., Ikeda N., Razak I.A., Axell T., Majid Z.A., Gupta P.C., et al. A national epidemiological survey of oral mucosal lesions in Malaysia. Community Dent Oral Epidemiol. 25:1997;377-383
6. Ikeda N., Ishii T., Iida S., Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol. 19:1991;160-163
7. Banoczy J., Rigo O. Prevalence study of oral precancerous lesions within a complex screening system in Hungary. Community Dent Oral Epidemiol. 19:1991;265-267
8. Reichart P.A., Kohn H. Prevalence of oral leukoplakia in 1000 Berliners. Oral Dis. 2:1996;291-294
9. Micheelis W., Reich E. The Third German Oral Health Study (DMS III). 1999;Institute of German Dentists (IDZ), Deutschen Ärtze-Verlag, Köln
10. Kovac-Kovacic M., Skaleric U. The prevalence of oral mucosal lesions in a population in Ljubljana, Slovenia. J Oral Pathol Med. 29:2000;331-335
11. Silverman S. Jr., Gorsky M., Lozada-Nur F., Giannotti K. A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol. 72:1991;665-670
12. Vincent S.D., Fotos P.G., Baker K.A., Williams T.P. Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol. 70:1990;165-171
13. Boisnic S., Frances C., Branchet M.C., Szpirglas H., Le Charpentier Y. Immunohistochemical study of oral lesions of lichen planus: diagnostic and pathophysiologic aspects. Oral Surg Oral Med Oral Pathol. 70:1990;462-465
14. Jungell P. Oral lichen planus. A review. Int J Oral Maxillofac Surg. 20:1991;129-135
15. Thornhill M.H. Immune mechanisms in oral lichen planus. Acta Odontol Scand. 59:2001;174-177
16. Hasseus B., Jontell M., Brune M., Johansson P., Dahlgren U.I. Langerhans cells and T cells in oral graft versus host disease and oral lichen planus. Scand J Immunol. 54:2001;516-524
17. Villarroel Dorrego M., Correnti M., Delgado R., Tapia F.J. Oral lichen planus: immunohistology of mucosal lesions. J Oral Pathol Med. 31:2002;410-414
18. Carrozzo M., Gandolfo S., Carbone M., Colombatto P., Broccoletti R., Garzino-Demo P., et al. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med. 25:1996;527-533
19. Chuang T.Y., Stitle L., Brashear R., Lewis C. Hepatitis C virus and lichen planus: a case-control study of 340 patients. J Am Acad Dermatol. 41:1999;787-789
20. Roy K., Bagg J. Hepatitis C virus and oral disease: a critical review. Oral Dis. 5:1999;270-277
21. Figueiredo L.C., Carrilho F.J., De Andrage H.F., Migliari D.A. Oral lichen planus and hepatitis C virus infection. Oral Dis. 8:2002;42-46
22. Nakamura S., Hiroki A., Shinohara M., Gondo H., Ohyama Y., Mouri T., et al. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 82:1996;556-563
23. Haddad J., Deny P., Munz-Gotheil C., Ambrosini J.C., Trinchet J.C., Pateron D., et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet. 339:1992;321-323
24. Pirisi M., Scott C., Fabris C., Ferraccioli G., Soardo G., Ricci R., et al. Mild sialoadenitis: a common finding in patients with hepatitis C virus infection. Scand J Gastroenterol. 29:1994;940-942
25. Hiroki A., Nakamura S., Shinohara M., Gondo H., Ohyama Y., Hayashi S., et al. A comparison of glandular involvement between chronic graft-versus-host disease and Sjögren's syndrome. Int J Oral Maxillofac Surg. 25:1996;298-307
26. Tanei R., Ohta Y., Katsuoka K. Lichen planus and Sjögren-type sicca syndrome in a patient with chronic hepatitis C. J Dermatol. 24:1997;20-27
27. Scott C.A., Avellini C., Desinan L., Pirisi M., Ferraccioli G.F., Bardus P., et al. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome. Histopathology. 30:1997;41-48
28. Cohen P. Extrahepatic manifestations of hepatitis C virus. Presse Med. 29:2000;209-214
29. Lundstrom I.M., Anneroth K.G., Bergstedt H.F. Salivary gland function and changes in patients with oral lichen planus. Scand J Dent Res. 90:1982;443-458
30. Tanei R., Katayama I., Katou I., Ota Y., Nishiyama S. Six cases of Sjögren's syndrome with lichen mucosae - studies on the histopathology of salivary gland and clinical manifestation of sicca features in the patients with lichen mucosae. Nippon Hifuka Gakkai Zasshi. 100:1990;1241-1249
31. Bermejo Fenoll A., Lopez Jornet M.P. Oral lichen planus and Sjögren's syndrome. 2 cases of association. Av Odontoestomatol. 7:1991;29-33. 36,38
32. Gart G.S., Camisa C. Ulcerative and oral lichen planus associated with sicca syndrome and primary biliary cirrhosis. Cutis. 53:1994;249-250
33. Chisholm D.M., Mason D.K. Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol. 21:1968;656-660
34. Greenspan J.S., Daniels T.E., Talal N., Sylvester R.A. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol. 37:1974;217-229
35. Ramon C., Bagan J.V., Milian M.A., Jimenez Y., Lloria E. Quantitative analysis of saliva in patients with oral lichen planus: a study of 100 cases. Med Oral. 5:2000;187-192
36. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res. 66:1987;648-653
37. Fox P.C., Busch K.A., Baum B.J. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc. 115:1987;581-584
38. Sreebny L.M., Valdini A. Xerostomia Part I: relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol. 66:1988;451-458
39. Main B.E., Calman K.C., Ferguson M.M., Kaye S.B., MacFarlane T.W., Mairs R.J., et al. The effect of cytotoxic therapy on saliva and oral flora. Oral Surg Oral Med Oral Pathol. 58:1984;545-548
40. Narhi T.O., Meurman J.H., Ainamo A. Xerostomia and hyposalivation: causes, consequences and treatment in the elderly. Drugs Aging. 15:1999;103-116
41. Daniels T.E. Evaluation, differential diagnosis, and treatment of xerostomia. J Rheumatol Suppl. 61:2000;6-10
42. Thomson W.M., Chalmers J.M., Spencer A.J., Slade G.D. Medication and dry mouth: findings from a cohort study of older people. J Public Health Dent. 60:2000;12-20
43. Thomson W.M., Chalmers J.M., Spencer A.J., Williams S.M. The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community Dent Health. 16:1999;12-17
44. Thomson W.M., Chalmers J.M., Spencer A.J., Ketabi M. The occurrence of xerostomia and salivary gland hypofunction in a population-based sample of older South Australians. Spec Care Dentist. 19:1999;20-23
45. Thomson W.M., Williams S.M. Further testing of the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 89:2000;46-50
46. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.I., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 61:2002;554-558
47. Locker D. Response and nonresponse bias in oral health surveys. J Public Health Dent. 60:2000;72-81
48. Burkhart N.W., Burker E.J., Burkes E.J., Wolfe L. Assessing the characteristics of patients with oral lichen planus. J Am Dent Assoc. 127:1996;648. 651-2, 655-6
49. Nederfors T., Dahlof C. Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human whole saliva flow rate and composition. Arch Oral Biol. 37:1992;579-584
50. Nederfors T., Ericsson T., Twetman S., Dahlof C. Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human parotid and submandibular-sublingual salivary secretion. J Dent Res. 73:1994;5-10
51. Nederfors T. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists. Swed Dent J Suppl. 116:1996;1-70
52. Varga E., Field E.A., Tyldesley W.R. Orofacial manifestations of mixed connective tissue disease. Br Dent J. 168:1990;330-331
53. Al-Najjar A., Reilly G.D., Harrington C. Dermatomyositis and lichen planus - an association or manifestation? Clin Exp Dermatol. 10:1985;174-178
54. Pindborg J.J. Diseases of the skin. Jones J.H., Mason D.K. Oral manifestations of systemic disease. 2nd ed. :1990;570-571 Baillière Tindall, London
55. Kovacs S.O., Kovacs S.C. Dermatomyositis. J Am Acad Dermatol. 39:1998;899-920
56. Cody D., Davidson J. Juvenile dermatomyositis and Sjögren's syndrome occurring concurrently in an adolescent male. Rheumatology (Oxford). 41:2002;698-700
57. Kubo M., Ihn H., Asano Y., Yamane K., Yazawa N., Tamaki K. Prevalence of 52-kd and 60-kd Ro/SS-A autoantibodies in Japanese patients with polymyositis/dermatomyositis. J Am Acad Dermatol. 47:2002;148-151